China Dasheng Biotechnology (CDBT) Stock Price, News & Analysis

Company Overview

China Dasheng Biotechnology Group Co., Ltd., trading under the symbol CDBT on the OTC Pink marketplace, is a China-based biotechnology company focused on the research, development and commercialization of veterinary biological products. The company specializes in diagnostic reagents, immunoassay kits and vaccines for the detection and prevention of infectious diseases in livestock and companion animals. Through internal research and development efforts and strategic industry partnerships, it aims to address critical animal health challenges in swine, poultry and cattle.

Its product portfolio extends to veterinary feed additives and nutrient supplements, including enzyme preparations and probiotics designed to support growth performance and disease resistance in farm animals. These offerings are marketed to feed manufacturers and livestock producers, enabling an integrated approach to animal health management by combining preventive care with diagnostic solutions.

China Dasheng Biotechnology primarily serves domestic markets in the People’s Republic of China while exploring opportunities for regional expansion. The company collaborates with academic institutions and industry experts to advance its product pipeline and navigate regulatory environments. As a smaller publicly traded entity, detailed information on its leadership team and corporate history is limited in publicly available sources.

Key Stats

• Today's Range: $0.09 to $0.09
• 50-Day Range: $0.02 to $0.09
• 52-Week Range: $0.00 to $0.15
• Volume: N/A
• Average Volume: 12,561 shs
• Market Capitalization: $3.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CDBT Stock Analysis - Frequently Asked Questions

How have CDBT shares performed this year?

China Dasheng Biotechnology's stock was trading at $0.0610 at the beginning of 2025. Since then, CDBT shares have increased by 47.5% and is now trading at $0.09.

How do I buy shares of China Dasheng Biotechnology?

Shares of CDBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of China Dasheng Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that China Dasheng Biotechnology investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU).

Company Calendar

• Today: 9/16/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Drug stores & proprietary stores
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:CDBT
• CIK: N/A
• Web: N/A
• Phone: (424) 358-1046
• Fax: 86-93-1844-1248
• Employees: 689
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 40,976,000
• Free Float: N/A
• Market Cap: $3.69 million
• Optionable: Not Optionable
• Beta: 2.25